findmyKOL
Clinical trialNCT00135876CompletedPhase 3Interventional

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

SponsorOntario Clinical Oncology Group (OCOG)Enrollment512Brain TumorsVenous Thromboembolism
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • the St. George Hospital

    Kogarah, New South Wales, Australia

  • Sir Charles Gairdner Hospital

    Nedlands, Western Australia, Australia

  • Royal Perth Hospital

    Perth, Western Australia, Australia

Canada
  • Cross Cancer Institute

    Edmonton, Alberta, Canada

  • Cancercare Manitoba

    Winnipeg, Manitoba, Canada

  • Nova Scotia Cancer Centre

    Halifax, Nova Scotia, Canada

  • the Ottawa Hospital Regional Cancer Centre

    Ottawa, Ontario, Canada

  • Princess Margaret Hospital

    Toronto, Ontario, Canada

  • Toronto-Sunnybrook Regional Cancer Centre

    Toronto, Ontario, Canada

Italy
  • Ospedali Riuniti Di Bergamo

    Bergamo, Italy

  • Università Di Perugia

    Perugia, Italy

United States
  • Kellogg Cancer Center - Evanston Northwestern Healthcare

    Evanston, Illinois, United States

  • Henry Ford Hospital

    Detroit, Michigan, United States

  • Huntsman Cancer Institute

    Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2002
Primary completion
—
Completion
30 Nov 2006
Last update posted
27 Apr 2007
Registered enrollment
512
Registry id
NCT00135876
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.